Ask AI
ProCE Banner Activity

Key Studies in Small-Cell Lung Cancer From the 2020 World Conference on Lung Cancer

Clinical Thought
Do you know about the key clinical trials in relapsed extensive-stage small-cell lung cancer presented at WCLC 2020?

Released: March 01, 2021

Share

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

AstraZeneca

Merck Sharp & Dohme Corp.

Faculty Disclosure

Primary Author

Nicolas Girard, MD, PhD

Head, Medical Oncology Department
Institut Curie
Paris, France
Full Professor
UVSQ Paris Saclay
Versailles, France

Nicolas Girard, MD, PhD, has disclosed that he has received consulting fees from AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Janssen, Merck Sharp & Dohme, Novartis, Pfizer, PharmaMar, Roche, Sanofi, and Teva, and funds for research support from AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Janssen, Merck Sharp & Dohme, Novartis, Pfizer, and Roche.